Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F22%3A10451513" target="_blank" >RIV/00669806:_____/22:10451513 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11140/22:10451513

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=pJEHzPCz70" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=pJEHzPCz70</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41379-022-01057-z" target="_blank" >10.1038/s41379-022-01057-z</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities

  • Popis výsledku v původním jazyce

    The category of &quot;oncocytic renal tumors&apos;&apos; includes well-recognized entities, such as renal oncocytoma (RO) and eosinophilic variant of chromophobe renal cell carcinoma (eo-ChRCC), as well as a group of &quot;gray zone&quot; oncocytic tumors, with overlapping features between RO and eo-ChRCC that create ongoing diagnostic and classification problems. These types of renal tumors were designated in the past as &quot;hybrid oncocytoma-chromophobe tumors&quot;. In a recent update, the Genitourinary Pathology Society (GUPS) proposed the term &quot;oncocytic renal neoplasm of low malignant potential, not further classified&quot;, for such solitary and sporadic, somewhat heterogeneous, but relatively indolent tumors, with equivocal RO/eo-ChRCC features. GUPS also proposed that the term &quot;hybrid oncocytic tumor&quot; be reserved for tumors found in a hereditary setting, typically arising as bilateral and multifocal ones (as in Birt-Hogg-Dube syndrome). More recent developments in the &quot;gray zone&quot; of oncocytic renal tumors revealed that potentially distinct entities may have been &quot;hidden&quot; in this group. Recent studies distinguished two new entities: &quot;Eosinophilic Vacuolated Tumor&quot; (EVT) and &quot;Low-grade Oncocytic Tumor&quot; (LOT). The rapidly accumulated evidence on EVT and LOT has validated the initial findings and has expanded the knowledge on these entities. Both are uniformly benign and are typically found in a sporadic setting, but rarely can be found in patients with tuberous sclerosis complex. Both have readily distinguishable morphologic and immunohistochemical features that separate them from similar renal tumors, without a need for detailed molecular studies. These tumors very frequently harbor TSC/MTOR mutations that are however neither specific nor restricted to these two entities. In this review, we outline a proposal for a working framework on how to classify such low-grade oncocytic renal tumors. We believe that such framework will facilitate their handling in practice and will stimulate further discussions and studies to fully elucidate their spectrum.

  • Název v anglickém jazyce

    Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities

  • Popis výsledku anglicky

    The category of &quot;oncocytic renal tumors&apos;&apos; includes well-recognized entities, such as renal oncocytoma (RO) and eosinophilic variant of chromophobe renal cell carcinoma (eo-ChRCC), as well as a group of &quot;gray zone&quot; oncocytic tumors, with overlapping features between RO and eo-ChRCC that create ongoing diagnostic and classification problems. These types of renal tumors were designated in the past as &quot;hybrid oncocytoma-chromophobe tumors&quot;. In a recent update, the Genitourinary Pathology Society (GUPS) proposed the term &quot;oncocytic renal neoplasm of low malignant potential, not further classified&quot;, for such solitary and sporadic, somewhat heterogeneous, but relatively indolent tumors, with equivocal RO/eo-ChRCC features. GUPS also proposed that the term &quot;hybrid oncocytic tumor&quot; be reserved for tumors found in a hereditary setting, typically arising as bilateral and multifocal ones (as in Birt-Hogg-Dube syndrome). More recent developments in the &quot;gray zone&quot; of oncocytic renal tumors revealed that potentially distinct entities may have been &quot;hidden&quot; in this group. Recent studies distinguished two new entities: &quot;Eosinophilic Vacuolated Tumor&quot; (EVT) and &quot;Low-grade Oncocytic Tumor&quot; (LOT). The rapidly accumulated evidence on EVT and LOT has validated the initial findings and has expanded the knowledge on these entities. Both are uniformly benign and are typically found in a sporadic setting, but rarely can be found in patients with tuberous sclerosis complex. Both have readily distinguishable morphologic and immunohistochemical features that separate them from similar renal tumors, without a need for detailed molecular studies. These tumors very frequently harbor TSC/MTOR mutations that are however neither specific nor restricted to these two entities. In this review, we outline a proposal for a working framework on how to classify such low-grade oncocytic renal tumors. We believe that such framework will facilitate their handling in practice and will stimulate further discussions and studies to fully elucidate their spectrum.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30109 - Pathology

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2022

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Modern Pathology

  • ISSN

    0893-3952

  • e-ISSN

    1530-0285

  • Svazek periodika

    35

  • Číslo periodika v rámci svazku

    9

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    11

  • Strana od-do

    1140-1150

  • Kód UT WoS článku

    000767067300001

  • EID výsledku v databázi Scopus

    2-s2.0-85126068879